المؤلفون: Johns K.R., Littlejohn G.O., Craven R.L.

مصطلحات الفهرس: rheumatic disease/dt [Drug Therapy], systemic lupus erythematosus/dt [Drug Therapy], thrombosis/si [Side Effect], azathioprine/dt [Drug Therapy], conjugated estrogen/ad [Drug Administration], conjugated estrogen/cb [Drug Combination], conjugated estrogen/do [Drug Dose], conjugated estrogen/pr [Pharmaceutics], corticosteroid/do [Drug Dose], corticosteroid/dt [Drug Therapy], cyproterone acetate plus estradiol valerate/ad [Drug Administration], cyproterone acetate plus estradiol valerate/do [Drug Dose], cyproterone acetate plus estradiol valerate/pr [Pharmaceutics], desogestrel plus ethinylestradiol/ad [Drug Administration], desogestrel plus ethinylestradiol/do [Drug Dose], desogestrel plus ethinylestradiol/pr [Pharmaceutics], diane/ad [Drug Administration], diane/do [Drug Dose], diane/pr [Pharmaceutics], estradiol/ad [Drug Administration], estradiol/cb [Drug Combination], estradiol/do [Drug Dose], estradiol/pr [Pharmaceutics], estradiol plus norethisterone acetate/ad [Drug Administration], estradiol plus norethisterone acetate/do [Drug Dose], estradiol plus norethisterone acetate/pr [Pharmaceutics], ethinylestradiol plus gestodene/ad [Drug Administration], ethinylestradiol plus gestodene/do [Drug Dose], ethinylestradiol plus gestodene/pr [Pharmaceutics], ethinylestradiol plus norethisterone, hydroxychloroquine/do [Drug Dose], hydroxychloroquine/dt [Drug Therapy], medroxyprogesterone acetate/ad [Drug Administration], medroxyprogesterone acetate/cb [Drug Combination], medroxyprogesterone acetate/do [Drug Dose], medroxyprogesterone acetate/pr [Pharmaceutics], oral contraceptive agent/ae [Adverse Drug Reaction], oral contraceptive agent/ad [Drug Administration], oral contraceptive agent/pr [Pharmaceutics], prednisolone/do [Drug Dose], prednisolone/dt [Drug Therapy], trisequens/ad [Drug Administration], trisequens/do [Drug Dose], trisequens/pr [Pharmaceutics], unclassified drug, improvil, monofeme, panafcortelone, trifeme, oral contraceptive agent/do [Drug Dose], ethinylestradiol plus levonorgestrel/ad [Drug Administration], ethinylestradiol plus levonorgestrel/do [Drug Dose], ethinylestradiol plus levonorgestrel/pr [Pharmaceutics], atherosclerosis/si [Side Effect], female, fibromyalgia/dt [Drug Therapy], gout/dt [Drug Therapy], hormone substitution, human, oral contraception, oral drug administration, osteoarthritis/dt [Drug Therapy], osteoporosis/si [Side Effect], pregnancy, review, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33965
Click here for full text options
LibKey Link

المؤلفون: Johns K.R., Littlejohn G.O., Craven R.L.

مصطلحات الفهرس: rheumatic disease/dt [Drug Therapy], systemic lupus erythematosus/dt [Drug Therapy], thrombosis/si [Side Effect], azathioprine/dt [Drug Therapy], conjugated estrogen/ad [Drug Administration], conjugated estrogen/cb [Drug Combination], conjugated estrogen/do [Drug Dose], conjugated estrogen/pr [Pharmaceutics], corticosteroid/do [Drug Dose], corticosteroid/dt [Drug Therapy], cyproterone acetate plus estradiol valerate/ad [Drug Administration], cyproterone acetate plus estradiol valerate/do [Drug Dose], cyproterone acetate plus estradiol valerate/pr [Pharmaceutics], desogestrel plus ethinylestradiol/ad [Drug Administration], desogestrel plus ethinylestradiol/do [Drug Dose], desogestrel plus ethinylestradiol/pr [Pharmaceutics], diane/ad [Drug Administration], diane/do [Drug Dose], diane/pr [Pharmaceutics], estradiol/ad [Drug Administration], estradiol/cb [Drug Combination], estradiol/do [Drug Dose], estradiol/pr [Pharmaceutics], estradiol plus norethisterone acetate/ad [Drug Administration], estradiol plus norethisterone acetate/do [Drug Dose], estradiol plus norethisterone acetate/pr [Pharmaceutics], ethinylestradiol plus gestodene/ad [Drug Administration], ethinylestradiol plus gestodene/do [Drug Dose], ethinylestradiol plus gestodene/pr [Pharmaceutics], ethinylestradiol plus norethisterone, hydroxychloroquine/do [Drug Dose], hydroxychloroquine/dt [Drug Therapy], medroxyprogesterone acetate/ad [Drug Administration], medroxyprogesterone acetate/cb [Drug Combination], medroxyprogesterone acetate/do [Drug Dose], medroxyprogesterone acetate/pr [Pharmaceutics], oral contraceptive agent/ae [Adverse Drug Reaction], oral contraceptive agent/ad [Drug Administration], oral contraceptive agent/pr [Pharmaceutics], prednisolone/do [Drug Dose], prednisolone/dt [Drug Therapy], trisequens/ad [Drug Administration], trisequens/do [Drug Dose], trisequens/pr [Pharmaceutics], unclassified drug, improvil, monofeme, panafcortelone, trifeme, oral contraceptive agent/do [Drug Dose], ethinylestradiol plus levonorgestrel/ad [Drug Administration], ethinylestradiol plus levonorgestrel/do [Drug Dose], ethinylestradiol plus levonorgestrel/pr [Pharmaceutics], atherosclerosis/si [Side Effect], female, fibromyalgia/dt [Drug Therapy], gout/dt [Drug Therapy], hormone substitution, human, oral contraception, oral drug administration, osteoarthritis/dt [Drug Therapy], osteoporosis/si [Side Effect], pregnancy, review, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33965
LibKey Link